BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DMFS TIME DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER PATIENT AGE PGR STATUS HISTOLOGICAL GRADE SIZE MM TREATMENT TYPE DFS TIME DSS TIME DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER CHARACTERISTICS HISTOLOGY YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS HER2 STATUS LN STATUS
GSM1100175 9.419 not specified 43 NA G1 21 none 9.42 NA not specified endocrine? (0=no, 1=yes): 0 NA not specified NA ER+ NA LN-
GSM1100174 10.614 1 37 NA G2 23 none 10.61 NA not specified endocrine? (0=no, 1=yes): 0 NA not specified NA ER- NA LN-
GSM1100173 7.151 1 67 NA NA 10 none 7.15 NA 1 endocrine? (0=no, 1=yes): 0 NA not specified NA ER- NA LN-
GSM1100172 1.66 NA 50 PgR- G3 29 CMFx6 NA 1.66027397260274 not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- He- LN-
GSM110017 4.51 NA 72 PgR- G2 20 tamoxifen NA 4.50958904109589 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100170 3.93 NA 56 PgR+ G1 30 tamoxifen NA 3.92602739726027 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100169 4.96 NA 46 PgR- G3 27 CMFx6; Tamoxifen NA 4.95890410958904 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- LN-
GSM1100168 4.56 NA 45 PgR+ G2 30 tamoxifen NA 4.56164383561644 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100167 5.01 NA 48 PgR- G3 60 CMFx6 NA 5.00821917808219 not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- He+ LN-
GSM1100166 4.64 NA 45 PgR+ G2 20 CMFx6 NA 4.64383561643836 not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- LN-
GSM1100165 5.13 NA 70 PgR- G2 20 tamoxifen NA 5.13424657534247 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100164 6.26 NA 59 PgR- G3 45 ACx4 NA 6.25753424657534 not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- NA LN-
GSM1100163 5.57 NA 61 PgR- G3 14 CMFx6; Arimidex/Tamoxifen NA 5.56712328767123 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- LN-
GSM1100162 5.11 NA 60 PgR+ G3 20 ACx4; Arimidex/Tamoxifen NA 5.10958904109589 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM110016 5.52 NA 53 PgR+ G3 19 tamoxifen NA 5.52328767123288 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100160 6.69 NA 42 PgR+ G2 14 CMFx6 NA 6.69315068493151 not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- LN-
GSM1100159 6.19 NA 73 PgR- NA 38 NA NA 6.18630136986301 not specified endocrine? (0=no, 1=yes): NA NA NA not specified ER- He- LN-
GSM1100158 2.57 NA 46 NA G3 32 CMFx6; Tamoxifen NA 2.57260273972603 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified NA NA LN-
GSM1100157 3.12 NA 57 PgR- G1 20 tamoxifen NA 3.11506849315069 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100156 5.94 NA 66 PgR+ G1 27 tamoxifen NA 5.93698630136986 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100155 6.13 NA 62 PgR+ G3 27 tamoxifen NA 6.12876712328767 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100154 6.61 NA 67 PgR- G3 40 ACx6; Tamoxifen NA 6.61369863013699 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- LN-
GSM1100153 6.65 NA 70 PgR- G2 35 tamoxifen NA 6.65205479452055 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100152 6.18 NA 77 PgR+ G2 15 tamoxifen NA 6.17534246575342 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM110015 6.02 NA 52 PgR- G2 20 ACx4; Tamoxifen NA 6.01917808219178 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He+ LN-
GSM1100150 7.57 NA 81 PgR- G2 20 tamoxifen NA 7.57260273972603 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100149 7.31 NA 55 PgR+ G3 18 tamoxifen NA 7.30684931506849 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100148 7.85 NA 48 NA G2 12 Tamoxifen+Zoledronic acid NA 7.85479452054795 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100147 7.82 NA 54 PgR- G2 10 tamoxifen NA 7.82191780821918 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- LN-
GSM1100146 3.30 NA 72 PgR+ G3 37 Arimidex/Tamoxifen NA 5.16438356164384 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ LN-
GSM1100145 3.65 NA 60 PgR+ G3 40 CMFx2; Tamoxifen NA 6.75068493150685 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM1100144 6.15 NA 54 PgR- G1 55 ACx4 NA 8.02191780821918 1 endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- LN-
GSM1100143 2.42 NA 36 PgR- G2 13 Tamoxifen+Zoledronic acid NA 7.07945205479452 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- LN-
GSM1100142 2.18 NA 46 PgR- G1 10 Tamoxifen+Zoledronic acid NA 2.18904109589041 not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- LN-
GSM110014 0.76 NA 70 PgR+ G3 35 tamoxifen NA 0.991780821917808 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ LN-
GSM1100140 3.80 NA 73 PgR- G3 34 ACx3/CMFx1 NA 4.62191780821918 1 endocrine? (0=no, 1=yes): 0 NA 1 1 ER- He- LN-
GSM1100139 2.21 NA 63 PgR+ G3 46 tamoxifen NA 4.92876712328767 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- LN-
GSM1100138 1.35 NA 38 PgR- G3 32 ECx4; Tamoxifen NA 2.75342465753425 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- LN-
GSM1100137 0.25 NA 57 PgR+ NA 85 tamoxifen NA 5.03561643835616 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ LN-
GSM1100136 4.51 NA 68 PgR+ G3 17 tamoxifen NA 6.17260273972603 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- LN-
GSM1100135 4.18 NA 66 PgR- G3 21 tamoxifen NA 4.19452054794521 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER- He- LN-
GSM1100134 0.65 NA 59 PgR- G3 25 tamoxifen NA 3.07945205479452 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER- He+ LN-
GSM1100133 1.39 NA 47 PgR+ G3 28 CMFx6; Tamoxifen NA 2.12602739726027 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ LN-
GSM1100132 3.05 NA 63 NA G2 30 tamoxifen NA 3.44931506849315 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ LN-
GSM110013 4.33 not specified 53 PgR+ G3 35 Tam+CMFx6 cycles 4.33 4.33 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ NA LN+
GSM1100130 4.83 not specified 59 PgR+ G1 60 NA 4.83 4.83 not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He- LN+
GSM1100129 4.38 not specified 62 PgR+ G3 20 tamoxifen 4.38 4.38 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100128 2.67 not specified 43 PgR+ G1 24 Tam+ACx4 cycles 2.67 2.67 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100127 4.67 not specified 55 NA G1 25 none 4.67 4.67 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma and papillary carcinoma not specified not specified NA NA LN-
GSM1100126 0.83 not specified 84 PgR+ G3 28 tamoxifen 0.83 0.83 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100125 2.00 1 38 PgR+ G3 40 Tam+AC 2.00 2.00 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100124 4.92 not specified 67 PgR- G3 25 tamoxifen 4.92 4.92 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100123 5.17 not specified 52 PgR+ G1 20 tamoxifen 5.17 5.17 not specified endocrine? (0=no, 1=yes): 1 invasive lobular carcinoma 1 not specified ER+ He- LN-
GSM1100122 3.83 1 50 PgR+ G3 16 Tam+ACx4 cycles 3.83 5.75 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM110012 5.21 not specified 64 PgR+ G3 50 tamoxifen 5.21 5.21 not specified endocrine? (0=no, 1=yes): 1 medullary carcinoma 1 not specified ER+ He+ LN-
GSM1100120 4.54 not specified 47 PgR+ G3 30 CAF 4.54 4.54 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100119 5.58 not specified 38 PgR+ G3 38 Tam+ACx4 cycles 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100118 5.92 not specified 58 PgR+ G3 51 Tam+ACx4 cycles 5.92 5.92 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100117 5.88 not specified 47 PgR- G3 21 ACx4 cycles 5.88 5.88 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100116 5.79 not specified 51 PgR- G3 18 Tam+CMFx6 cycles 5.79 5.79 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100115 5.83 not specified 48 PgR- G3 35 ACx4 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100114 5.83 not specified 46 PgR- G3 25 ACx4 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN-
GSM1100113 1.33 1 51 PgR- G3 27 ACx4 cycles 1.92 5.58 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100112 6.17 not specified 36 PgR+ G3 25 Tam+CMFx6 cycles 6.17 6.17 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100 5.83 not specified 61 PgR- G3 15 CAFx6 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100110 5.71 not specified 48 PgR- G3 32 ACx4 cycles 5.71 5.71 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100109 5.88 not specified 61 PgR- G3 25 CMF 5.88 5.88 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100108 1.17 not specified 42 PgR- G3 20 none 1.17 6.50 not specified endocrine? (0=no, 1=yes): 0 medullary carcinoma not specified not specified ER- He- LN-
GSM1100107 3.50 not specified 77 PgR+ G1 40 tamoxifen 3.50 4.33 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100106 NA NA 81 PgR+ G1 40 tamoxifen NA NA NA endocrine? (0=no, 1=yes): 1 papillary carcinoma 1 NA ER+ He- LN-
GSM1100105 4.00 not specified 42 PgR- G3 23 NA 4.00 4.00 not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER- He+ LN-
GSM1100104 2.29 1 38 PgR- G3 36 Tam+ACx4 cycles 2.29 2.88 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100103 0.79 1 51 PgR- G3 30 ACx4 cycles 0.79 1.46 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100102 5.58 not specified 60 PgR+ G1 15 Tam+CMFx6 cycles 5.58 5.79 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM110010 6.29 not specified 52 PgR+ G3 45 Tam+ACx4 cycles 6.29 6.29 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100100 0.75 not specified 48 PgR- G3 35 ACx4 cycles 0.75 0.75 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN-
GSM1100099 4.17 not specified 42 PgR- G3 22 AC 4.17 4.25 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN-
GSM1100098 5.08 not specified 48 PgR- G3 30 ACx4 cycles 5.08 5.08 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN+
GSM1100097 4.38 not specified 34 PgR+ G3 35 ACx8 cycles; taxol 4.38 4.38 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100096 2.21 1 29 PgR+ G1 80 CAFx6 cycles 2.21 3.04 1 endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 1 ER+ He- LN+
GSM1100095 3.13 not specified 86 PgR+ G1 21 tamoxifen 3.13 4.38 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100094 1.29 1 54 PgR- G3 35 CAF 1.29 1.38 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 1 ER- He+ LN+
GSM1100093 0.13 1 46 PgR- G3 22 NA 0.13 0.38 1 endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA 1 ER- He+ LN+
GSM1100092 5.54 not specified 41 PgR- G3 40 ACx4 cycles 5.54 5.54 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN-
GSM110009 1.96 1 80 PgR+ G3 40 tamoxifen 1.96 1.96 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100090 4.83 not specified 45 PgR- G3 20 CAF 4.83 4.83 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100089 5.08 not specified 64 PgR- G3 30 ACx4 cycles 5.08 5.08 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100088 0.88 1 62 PgR- G3 35 none 0.88 1.00 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ LN+
GSM1100087 0.00 1 62 PgR+ G3 25 Arimidex+CMFx2 cycles 0.00 2.08 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ LN+
GSM1100086 1.96 not specified 58 PgR+ G3 30 CAF 1.96 1.96 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100085 5.25 not specified 45 PgR+ G3 25 AC 5.25 5.29 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100084 3.96 1 54 PgR- G3 20 ACx4 cycles 3.96 4.63 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 1 ER- He+ LN+
GSM1100083 4.00 not specified 44 PgR- G3 50 ACx4 cycles 4.00 4.00 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- NA LN+
GSM1100082 2.04 1 74 PgR- G3 30 tamoxifen 2.04 2.25 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ LN+
GSM110008 4.00 not specified 52 PgR- G3 35 ACx4 cycles 4.00 4.33 not specified endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 not specified ER- He+ LN+
GSM1100080 1.00 not specified 55 PgR- G3 60 ACx4 cycles 1.00 5.00 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100079 0.13 not specified 66 PgR+ G1 38 tamoxifen NA 0.13 not specified endocrine? (0=no, 1=yes): 1 mucinous carcinoma 1 not specified ER+ He- LN-
GSM1100078 4.88 not specified 47 PgR+ G3 32 CAF 4.88 4.88 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100077 4.46 not specified 55 PgR+ G3 20 tamoxifen 4.46 4.46 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100076 5.46 not specified 45 PgR+ G1 15 tamoxifen;goserelin 5.46 5.46 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100075 1.54 not specified 34 PgR- G3 40 ACx4 cycles 1.54 5.46 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN-
GSM1100074 5.00 not specified 47 PgR+ G2 35 ACx4 cycles 5.00 5.00 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100073 5.33 not specified 49 PgR+ G2 15 tamoxifen 5.33 5.33 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100072 5.58 not specified 64 PgR+ G2 12 tamoxifen 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM110007 NA NA 66 PgR+ G2 17 NA NA 0.08 NA endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He+ LN-
GSM1100070 4.00 not specified 46 PgR+ G2 40 NA 4.00 4.50 not specified endocrine? (0=no, 1=yes): NA invasive ductal and lobular carcinoma NA not specified ER- He- LN+
GSM1100069 4.83 not specified 73 PgR+ G2 20 tamoxifen 4.83 4.92 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100068 4.88 not specified 46 PgR+ G2 15 Tam+CMFx6 cycles 4.88 4.88 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100067 4.50 not specified 42 PgR- G2 30 NA 4.50 4.50 not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He- LN+
GSM1100066 1.67 1 46 PgR- G2 60 Tam+CAFx2 cycles 1.67 1.75 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ LN+
GSM1100065 0.42 not specified 44 PgR+ G2 24 none 0.42 0.42 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER+ He+ LN+
GSM1100064 4.92 not specified 55 PgR+ G2 19 tamoxifen 4.92 4.92 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100063 4.75 not specified 57 PgR+ G2 21 tamoxifen 4.75 4.75 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100062 5.17 not specified 40 PgR+ G2 23 CAF 5.17 5.17 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM110006 4.67 not specified 44 PgR+ G2 35 CMF 4.67 4.67 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100060 5.67 not specified 46 PgR+ G2 30 CAF 5.67 5.67 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100059 4.67 not specified 35 PgR+ G2 40 Tam+ACx4 cycles 4.67 4.67 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He- LN-
GSM1100058 0.67 1 55 PgR+ G2 15 none 1.25 4.58 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER+ He- LN-
GSM1100057 2.83 1 67 PgR- G2 25 none 2.83 2.83 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ LN-
GSM1100056 0.67 1 75 PgR+ G2 40 tamoxifen 0.92 5.42 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100055 0.04 1 48 PgR- G2 15 anastrozole;taxol 0.04 3.08 1 endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 1 ER+ He- LN-
GSM1100054 5.25 not specified 49 PgR+ G2 23 Tam+CAFx6 cycles 5.25 5.25 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN+
GSM1100053 5.00 not specified 69 PgR+ G2 25 CAF 5.00 5.00 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN+
GSM1100052 NA NA 51 PgR- G2 25 Tam+ACx8;taxol NA NA NA endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 NA ER+ He+ LN+
GSM110005 6.33 not specified 60 PgR+ G2 20 Tam+CMFx6 cycles 6.33 6.33 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100050 5.58 not specified 77 PgR- G2 35 tamoxifen 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100049 5.75 not specified 53 PgR+ G2 22 CMF 5.75 5.92 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN+
GSM1100048 5.83 not specified 50 PgR+ G2 25 CAF 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- LN+
GSM1100047 5.79 not specified 52 PgR+ G2 18 CMF 5.79 5.79 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100046 6.00 not specified 53 PgR- G2 18 tamoxifen 6.00 6.00 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100045 4.04 not specified 46 PgR- G2 15 none 4.04 4.08 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ LN-
GSM1100044 5.63 not specified 48 PgR+ G2 20 NA 5.63 5.63 not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He+ LN-
GSM1100043 2.00 1 54 PgR- G2 60 ACx4 cycles 2.00 2.25 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100042 6.25 not specified 69 PgR- G2 25 tamoxifen 6.25 6.25 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM110004 2.63 not specified 40 PgR+ G2 25 Tam+CMFx6 cycles 2.63 2.63 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ LN-
GSM1100040 5.88 not specified 69 PgR+ G2 35 tamoxifen 5.88 6.04 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100039 4.29 not specified 69 PgR+ G2 30 tamoxifen 4.29 4.29 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-
GSM1100038 1.13 1 62 PgR- G2 30 ACx4 cycles 1.13 1.13 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ LN+
GSM1100037 6.17 not specified 41 PgR+ G2 20 Tam+ACx4 cycles 6.17 6.17 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- LN-

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use